PhenMap AI tool identifies bowel cancer patients unlikely to benefit from bevacizumab
Institute of Cancer Research study uses AI to flag advanced bowel cancer patients at high risk of poor response to NHS-approved drug bevacizumab.
1 article tagged Cancer Research
Institute of Cancer Research study uses AI to flag advanced bowel cancer patients at high risk of poor response to NHS-approved drug bevacizumab.